92% of US seniors enrolled in the Medicare Part D prescription drug benefit are satisfied with their coverage, according to a national telephone survey by advocacy group RetireSafe. The findings are consistent with previous studies since the program's 2006 launch (Marketletters passim).
Other findings from the RetireSafe study include: 90% of respondents thought their individual plan covered a wide enough range of drugs; 85% found costs manageable; and 81% were likely not to change their provider in 2009. The annual Part D enrollment period started on November 15.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze